Institutional Ownership Centessa Pharmaceuticals PLC (CNTA)
This table provides information about the institutional ownership of Centessa Pharmaceuticals PLC (CNTA). We have compiled data on the 118 institutions that hold shares in the stock, with a total of 124 Million shares, which have been reported (via 13F filing form) to have a value of $2.01 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Affinity Asset Advisors, LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
1,095,924
shares
|
$17.3 Million
3.28% of portfolio
|
Q4 2024
Added 13.5%
|
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
1,079,708
shares
|
$17.1 Million
0.01% of portfolio
|
Q4 2024
Reduced 5.25%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,070,209
shares
|
$16.9 Million
0.0% of portfolio
|
Q4 2024
Added 21274.26%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
830,945
shares
|
$13.1 Million
6.18% of portfolio
|
Q4 2024
Reduced 35.34%
|
|
|
Tanager Wealth Management LLP
|
Jan 27, 2025 Q4 2024 |
696,096
shares
|
$11 Million
1.51% of portfolio
|
Q2 2023
Reduced 5.56%
|
|
|
Stem Point Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
641,964
shares
|
$10.1 Million
2.68% of portfolio
|
Q4 2024
Added 667.33%
|
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
641,714
shares
|
$10.1 Million
0.01% of portfolio
|
Q4 2024
Added 14.86%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
625,316
shares
|
$9.88 Million
0.0% of portfolio
|
Q4 2024
Added 6.43%
|
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
598,952
shares
|
$9.46 Million
2.41% of portfolio
|
Q4 2024
Reduced 19.56%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
545,645
shares
|
$8.62 Million
0.07% of portfolio
|
Q4 2024
Added 5.67%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
512,647
shares
|
$8.1 Million
0.43% of portfolio
|
Q3 2024
Added 13.92%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
464,622
shares
|
$7.34 Million
0.0% of portfolio
|
Q2 2024
Added 21.48%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Feb 14, 2025 Q4 2024 |
440,495
shares
|
$6.96 Million
0.02% of portfolio
|
Q4 2024
Added 63.63%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
398,451
shares
|
$6.3 Million
0.0% of portfolio
|
Q4 2024
Added 72.95%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
371,766
shares
|
$5.87 Million
0.41% of portfolio
|
Q4 2024
Added 38.12%
|
|
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
Feb 10, 2025 Q4 2024 |
370,278
shares
|
$5.85 Million
0.37% of portfolio
|
Q4 2024
Reduced 13.83%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
365,200
shares
|
$5.77 Million
0.04% of portfolio
|
Q4 2024
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
317,329
shares
|
$5.01 Million
0.0% of portfolio
|
Q4 2024
Added 19.76%
|
|
|
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
303,479
shares
|
$4.79 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Allostery Investments LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
284,517
shares
|
$4.5 Million
4.98% of portfolio
|
Q4 2024
New holding
|
|
|
Trexquant Investment LP
Stamford, CT |
Feb 12, 2025 Q4 2024 |
261,184
shares
|
$4.13 Million
0.05% of portfolio
|
Q4 2024
Added 52.78%
|
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
244,538
shares
|
$3.86 Million
4.65% of portfolio
|
Q4 2024
Reduced 21.02%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Feb 14, 2025 Q4 2024 |
220,000
shares
|
$3.48 Million
1.58% of portfolio
|
Q4 2024
Reduced 13.73%
|
|
|
Fred Alger Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
190,451
shares
|
$3.01 Million
0.02% of portfolio
|
Q4 2024
Added 7.26%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
190,385
shares
|
$3.01 Million
0.0% of portfolio
|
Q4 2024
Added 40.09%
|